In both inflammatory and malignant conditions—particularly in inflammatory bowel diseases such as Crohn’s disease and ulcerative colitis, as well as in MS and rheumatoid arthritis (RA)—MDK has emerged as a cytokine of diagnostic significance [60]. Here, MDK is linked to myeloid sarcoma.